Including persons with HIV infection in cancer clinical trials

被引：71
作者：
Persad, Govind C. [1 ,2 ]
Little, Richard F. [1 ,2 ]
Grady, Christine [1 ,2 ]
机构：
[1] NCI, Dept Bioeth, Ctr Clin, Bethesda, MD 20892 USA
[2] NCI, Clin Invest Branch, Canc Therapy Evaluat Program, Div Canc Therapy & Diagnosis,Natl Inst Hlth, Bethesda, MD 20892 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 07期
关键词：
D O I：
10.1200/JCO.2007.14.5532
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1027 / 1032
页数：6
相关论文
共 50 条
[1]   Human immunodeficiency virus infection and kidney transplantation in the era of highly active antiretroviral therapy and modern immunosuppression [J].
Abbott, KC ;
Swanson, SJ ;
Agodoa, LYC ;
Kimmel, PL .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2004, 15 (06) :1633-1639
[2]   Enrollment of African Americans onto clinical treatment trials: Study design barriers [J].
Adams-Campbell, LL ;
Ahaghotu, C ;
Gaskins, M ;
Dawkins, FW ;
Smoot, D ;
Polk, OD ;
Gooding, R ;
Dewitty, RL .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (04) :730-734
[3]  
*AEGIS CATIE NEWS, 2003, LUNG CANC HIV POS HA
[4]  
[Anonymous], NAT HIV PREV C ATL G
[5]   Better response to chemotherapy and prolonged survival in AIDS-related lymphomas responding to highly active antiretroviral therapy [J].
Antinori, A ;
Cingolani, A ;
Alba, L ;
Ammassari, A ;
Serraino, D ;
Ciancio, BC ;
Palmieri, F ;
De Luca, A ;
Larocca, LM ;
Ruco, L ;
Ippolito, G ;
Cauda, R .
AIDS, 2001, 15 (12) :1483-1491
[6]   HIV testing in early clinical trials: Who should decide whether it is warranted? [J].
Apseloff, G .
JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 42 (06) :601-604
[7]  
BALSALOBRE P, 2006, 32 ANN M EUR GROUP B
[8]   Malignancy-related causes of death in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy [J].
Bonnet, F ;
Lewden, C ;
May, T ;
Heripret, L ;
Jougla, E ;
Bevilacqua, S ;
Costagliola, D ;
Salmon, D ;
Chêne, G ;
Morlat, P .
CANCER, 2004, 101 (02) :317-324
[9]   Incidence and risk factors for the occurrence of non-AIDS-defining cancers among human immunodeficiency virus-infected individuals [J].
Burgi, A ;
Brodine, S ;
Wegner, S ;
Milazzo, M ;
Wallace, MR ;
Spooner, K ;
Blazes, DL ;
Agan, BK ;
Armstrong, A ;
Fraser, S ;
Crum, NF .
CANCER, 2005, 104 (07) :1505-1511
[10]  
*CDCP DEP HLTH HUM, 2005, HIV AIDS SURV REP 20
12345